These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36627183)

  • 1. Impact of policy alterations on elective percutaneous coronary interventions in Japan.
    Morishita T; Takada D; Shin JH; Kunisawa S; Fushimi K; Imanaka Y
    Heart; 2023 Mar; 109(8):612-618. PubMed ID: 36627183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rates of Elective Percutaneous Coronary Intervention in England and Wales: Impact of COURAGE and ORBITA Trials.
    Rashid M; Stevens C; Wijeysundera HC; Curzen N; Khoo CW; Mohamed MO; Aktaa S; Wu J; Ludman PF; Mamas MA
    J Am Heart Assoc; 2022 Sep; 11(18):e025426. PubMed ID: 36102261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world use of intravascular ultrasound in Japan: a report from contemporary multicenter PCI registry.
    Kuno T; Numasawa Y; Sawano M; Abe T; Ueda I; Kodaira M; Suzuki M; Noma S; Nakamura I; Negishi K; Ishikawa S; Fukuda K; Kohsaka S
    Heart Vessels; 2019 Nov; 34(11):1728-1739. PubMed ID: 31129872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of elective percutaneous coronary intervention on microvascular resistance: a serial assessment using the index of microcirculatory resistance.
    Murai T; Lee T; Kanaji Y; Matsuda J; Usui E; Araki M; Niida T; Hishikari K; Ichijyo S; Hamaya R; Yonetsu T; Isobe M; Kakuta T
    Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H520-31. PubMed ID: 27342881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of Patients With Angina Pectoris Undergoing Percutaneous Coronary Intervention With Intracoronary Pressure Wire Guidance.
    Völz S; Dworeck C; Redfors B; Pétursson P; Angerås O; Gan LM; Götberg M; Sarno G; Venetsanos D; Grimfärd P; Hofmann R; Jensen J; Björklund F; Danielewicz M; Linder R; Råmunddal T; Fröbert O; Witt N; James S; Erlinge D; Omerovic E
    J Am Coll Cardiol; 2020 Jun; 75(22):2785-2799. PubMed ID: 32498806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appropriateness-based reimbursement of elective invasive coronary procedures in low- and middle-income countries: Preliminary assessment of feasibility in India.
    Karthikeyan G; Shirodkar U; Lochan MR; Birch S
    Natl Med J India; 2017; 30(1):11-14. PubMed ID: 28731000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and clinical impact of stroke complicating percutaneous coronary intervention: results of the Euro heart survey percutaneous coronary interventions registry.
    Werner N; Bauer T; Hochadel M; Zahn R; Weidinger F; Marco J; Hamm C; Gitt AK; Zeymer U
    Circ Cardiovasc Interv; 2013 Aug; 6(4):362-9. PubMed ID: 23899872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appropriateness of elective percutaneous coronary intervention and impact of government health insurance scheme - A tertiary centre experience from Western India.
    Patil D; Lanjewar C; Vaggar G; Bhargava J; Sabnis G; Pahwa J; Phatarpekar A; Shah H; Kerkar P
    Indian Heart J; 2017; 69(5):600-606. PubMed ID: 29054183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in percutaneous coronary intervention practice in Japan during the COVID-19 outbreak: LIFE Study.
    Maeda M; Fukuda H; Kiyohara K; Miki R; Kitamura T
    Acute Med Surg; 2021; 8(1):e638. PubMed ID: 33738105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chest pain after percutaneous coronary intervention in patients with stable angina.
    Chang CC; Chen YC; Ong ET; Chen WC; Chang CH; Chen KJ; Chiang CW
    Clin Interv Aging; 2016; 11():1123-8. PubMed ID: 27574412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and impact on prognosis of peri-procedural myocardial infarction in 2760 elective patients with stable angina pectoris in a historical prospective follow-up study.
    Christensen MK; Huang H; Torp-Pedersen C; Trydal T; Ravkilde J
    BMC Cardiovasc Disord; 2016 Jun; 16():140. PubMed ID: 27305902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial of landiolol, a short-acting beta-1 adrenergic receptor blocker, illustrating changes in high-molecular weight adiponectin levels after elective percutaneous coronary intervention.
    Kiyokuni M; Konishi M; Saigusa Y; Iwata K; Nakayama N; Komura N; Sugano T; Ishigami T; Ishikawa T; Yamanaka T; Tamura K; Kimura K
    Heart Vessels; 2020 Nov; 35(11):1510-1517. PubMed ID: 32533314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should We Postpone Elective Cardiovascular Procedures and Percutaneous Coronary Interventions During the COVID-19 Pandemic?
    Keskin G; Khalil E; Uysal A
    Heart Surg Forum; 2021 Jan; 24(1):E022-E030. PubMed ID: 33635255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-3 polyunsaturated fatty acids do not influence the efficacy of dual antiplatelet therapy in stable angina pectoris patients after percutaneous coronary intervention.
    Mizia-Stec K; Mizia M; Haberka M; Lasota B; Gieszczyk-Strózik K; Chmiel A; Najda J; Gąsior Z; Kyrcz-Krzemień S
    Cardiol J; 2013; 20(5):478-85. PubMed ID: 24469870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicorandil prevents microvascular dysfunction resulting from PCI in patients with stable angina pectoris: a randomised study.
    Hirohata A; Yamamoto K; Hirose E; Kobayashi Y; Takafuji H; Sano F; Matsumoto K; Ohara M; Yoshioka R; Takinami H; Ohe T
    EuroIntervention; 2014 Jan; 9(9):1050-6. PubMed ID: 24457276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medium-Term Impact of the Coronavirus Disease 2019 Pandemic on the Practice of Percutaneous Coronary Interventions in Japan.
    Watanabe S; Shin JH; Morishita T; Takada D; Kunisawa S; Imanaka Y
    J Atheroscler Thromb; 2022 Nov; 29(11):1571-1587. PubMed ID: 34924456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of systemic pentraxin-3 values with coronary plaque components on optical coherence tomography and post-percutaneous coronary intervention outcomes in patients with stable angina pectoris.
    Kimura S; Sugiyama T; Hishikari K; Nakagama S; Nakamura S; Misawa T; Mizusawa M; Hayasaka K; Yamakami Y; Sagawa Y; Kojima K; Ohtani H; Hikita H; Takahashi A
    Atherosclerosis; 2020 Jan; 292():127-135. PubMed ID: 31805452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial.
    Ferrari R; Ford I; Fox K; Challeton JP; Correges A; Tendera M; Widimský P; Danchin N;
    Lancet; 2020 Sep; 396(10254):830-838. PubMed ID: 32877651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry.
    Motivala AA; Parikh V; Roe M; Dai D; Abbott JD; Prasad A; Mukherjee D
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1639-48. PubMed ID: 27539683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preprocedural fractional flow reserve and microvascular resistance predict increased hyperaemic coronary flow after elective percutaneous coronary intervention.
    Murai T; Kanaji Y; Yonetsu T; Lee T; Matsuda J; Usui E; Araki M; Niida T; Isobe M; Kakuta T
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):233-242. PubMed ID: 27219714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.